0
Marketing authorisation (MA) of a medicinal product is the process of reviewing and assessing the evidence to support that product, in relation to its marketing, finalized by granting of a licence...
More >- INICIO
-
Genéricos
Novedades
- Sandoz launches ferumoxytol and pemetrexed generics
- US generic approvals for Acrux and Cipla
- Natco cancer generic approval and advances for Lannett asthma and diabetes products
- FDA approval for schizophrenia and HIV generics from Zydus Cadila and Lupin
Investigación
- Generic pharmaceutical policies in the MENA region
- El mercado de los medicamentos genéricos en Brasil
- Leyes sobre el envasado, sustitución y prescripción de medicamentos genéricos en Brasil
- Requisitos legales sobre estudios de equivalencia para medicamentos genéricos en Brasil
-
Biosimilares
Novedades
- Bevacizumab biosimilars launched in Spain and Korea
- Mabpharm gains approval for infliximab biobetter in China
- Formycon/Bioeq submit European marketing authorization for ranibizumab biosimilar
- Human insulin ‘similar biologic’ InsuTrend launched in India
Investigación
- Colaboración entre autoridades reguladoras sobre biosimilares
- Clinical pharmacists have a critical role in increasing biosimilar uptake
- Clinical development of biosimilars in the oncology setting
- Conocimiento y percepciones de la denominación de biosimilares en EE. UU.
- MORE EDITORIAL SECTIONS
- Search
